Development and Validation of Adherence Score for Subcutaneous Biologic Disease-Modifying Antirheumatic Drugs

Background: The biologic disease-modifying antirheumatic drugs (bDMARDs) are currently incorporated as part of the pharmacotherapy management of inflammatory arthritis (IA). Adherence to bDMARDs is crucial to ensure treatment success in IA. However, most of the recent studies evaluated adherence lev...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdul Razak, Salmi, Makmor Bakry, Mohd, Mohamed Said, Mohd Shahrir, Tan, Chai-Eng, Md Redzuan, Adyani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7681069/
https://www.ncbi.nlm.nih.gov/pubmed/33240088
http://dx.doi.org/10.3389/fphar.2020.572260

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7681069/
https://www.ncbi.nlm.nih.gov/pubmed/33240088
http://dx.doi.org/10.3389/fphar.2020.572260

Ejemplares similares